Takeshi Sasaki

Tokyo, 1130033, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer.

Multicenter ex vivo evaluation of an α-mannosidase-targeted fluorescent probe for intraoperative margin assessment in breast cancer.

Journal: Scientific reports
Published: December 30, 2025

A novel quantification method for automatic computation of breast density from mammography images using deep learning.

A novel quantification method for automatic computation of breast density from mammography images using deep learning.

Journal: Breast cancer (Tokyo, Japan)
Published: August 31, 2025

4. How to Decide Breast Cancer Therapy According to Pathological Condition?

4. How to Decide Breast Cancer Therapy According to Pathological Condition?

Journal: Nihon Hoshasen Gijutsu Gakkai zasshi
Published: July 20, 2022

Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements.

Development of an intraoperative breast cancer margin assessment method using quantitative fluorescence measurements.

Journal: Scientific reports
Published: January 05, 2022

Automatic Quantification of Breast Density from Mammography Using Deep Learning

Automatic Quantification of Breast Density from Mammography Using Deep Learning

Journal: Nihon Hoshasen Gijutsu Gakkai zasshi
Published: October 21, 2021

Quantitative assessment of HER2 gene amplification of breast cancer using droplet digital PCR.

Quantitative assessment of HER2 gene amplification of breast cancer using droplet digital PCR.

Journal: Pathology international
Published: February 09, 2021

Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer.

Loss of BRCA1 expression and morphological features associated with BRCA1 promoter methylation status in triple-negative breast cancer.

Journal: Journal of human genetics
Published: November 15, 2020

Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.

Droplet-digital PCR reveals frequent mutations in TERT promoter region in breast fibroadenomas and phyllodes tumours, irrespective of the presence of MED12 mutations.

Journal: British journal of cancer
Published: December 23, 2019

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.

Anthracycline could be essential for triple-negative breast cancer: A randomised phase II study by the Kanagawa Breast Oncology Group (KBOG) 1101.

Journal: Breast (Edinburgh, Scotland)
Published: January 05, 2019

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.

Proposal for a Risk-Based Categorization of Uterine Carcinosarcoma.

Journal: Annals of surgical oncology
Published: May 14, 2018

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.

Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.

Journal: Annals of surgical oncology
Published: February 27, 2018

The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization.

The analysis of human papillomavirus DNA in penile cancer tissue by in situ hybridization.

Journal: Oncology letters
Published: August 24, 2017
Showing 1-12 of 29

Last Updated: 09/26/2026